The $1.8bn acquisition of Ally Bridge Group portfolio company ProfoundBio by Genmab is now complete. Congratulations to all stakeholders of ProfoundBio, in particular the three scientific co-founders Baiteng Zhao, Tae Han, Xiao Shang. Excited that your work will continue on in the capable hands of Genmab for the benefit of cancer patients. #venturecapital #biotech #innovation #medicine #healthcare
Ally Bridge Group
Financial Services
New York, New York 1,171 followers
We focus on high-impact life science innovation addressing unmet medical needs.
About us
Ally Bridge Group is a global healthcare manager focused on high-impact life science innovation across private and public markets. Founded in 2013 by Frank Yu, Co-Chief Executive Officer and Co-Chief Investment Officer, the firm manages assets from offices in New York and Hong Kong. Our mission is to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. We aim to achieve this by blending deep scientific and clinical research with financial and capital markets expertise.
- Website
-
http://www.ally-bridge.com
External link for Ally Bridge Group
- Industry
- Financial Services
- Company size
- 11-50 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Healthcare
Locations
-
Primary
Get directions
430 Park Avenue
12th Floor
New York, New York 10022, US
-
Get directions
15 Queen’s Road
Gloucester Tower, The Landmark, 30th Floor
Central, HK